Login / Signup

The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.

Soyi LimYun Hwan KimKwang Beom LeeJong Min Lee
Published in: Journal of gynecologic oncology (2018)
Postoperative hormone therapy with DRSP/E2 in EC survivors did not increase recurrence or the death rate.
Keyphrases
  • endometrial cancer
  • patients undergoing
  • young adults
  • stem cells
  • mesenchymal stem cells
  • bone marrow
  • free survival